Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release.
Drug targeting to the colon via the oral administration route for local treatment of e.g. inflammatory bowel disease and colonic cancer has several advantages such as needle-free administration and low infection risk. A new source for delivery is plant-polysaccharide based delivery platforms such as...
Main Authors: | Anna J Svagan, Anja Kusic, Cristian De Gobba, Flemming H Larsen, Philip Sassene, Qi Zhou, Marco van de Weert, Anette Mullertz, Bodil Jørgensen, Peter Ulvskov |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5167381?pdf=render |
Similar Items
-
Rhamnogalacturonan I and cell development
by: Verhertbruggen, Yves
Published: (2008) -
Synthesis of borate cross-linked rhamnogalacturonan II
by: Hiroya eFunakawa, et al.
Published: (2015-04-01) -
The release of thiabendazole from microcapsules and tabletted microcapsules
by: Hassan, M. A. M.
Published: (1980) -
Towards the synthesis of rhamnogalacturonan-II side-chain A
by: Chauvin, Anne-Laure
Published: (2005) -
Establishing the developmental function of the rhamnogalacturonan II component of pectin
by: Smyth, Kevin
Published: (2012)